A recent publication in Nature showed that in pancreatic adenocarcinoma (PDAC), the primary source of Grem1 expression is derived from tumor cells that have undergone epithelial-to-mesenchymal transition (EMT) and lost EpCAM expression (Lan et al. 2022). Here, GREM1 is linked to neoplasm.